4
Changes in Ownership
NEOGENOMICS INC Filed Acc 0001077183-21-000249
Chief Strategy Officer sold 100,000 shares at an average $36.96 ($3,696,000)
From the SEC's structured data for this filing
Trades in this filing
Brown Douglas Matthew · Chief Strategy Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-23 | Sale : show line 1 in the form | −33,333 | $37.19 | $1,239,654 | 78,311 | D |
| 2021-11-24 | Sale : show line 2 in the form | −33,333 | $36.84 | $1,227,988 | 44,978 | D |
| 2021-11-26 | Sale : show line 3 in the form | −33,334 | $36.85 | $1,228,358 | 11,644 | D |
| Open-market sales · 100,000 sh · avg $36.96 · $3,696,000 | ||||||
Loading xslF345X03/wf-form4_163796128276463.xml…